Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$148.40
-2.0%
$141.70
$108.35
$163.75
$41.92B1.242.24 million shs194,209 shs
Bruker Corporation stock logo
BRKR
Bruker
$57.92
-1.9%
$58.84
$28.95
$65.30
$8.81B1.262.36 million shs107,223 shs
Revvity Inc. stock logo
RVTY
Revvity
$128.14
-2.1%
$115.72
$81.22
$133.00
$14.29B1.091.40 million shs233,147 shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$72.36
+0.1%
$71.78
$43.19
$72.62
$11.35B1.283.36 million shs889,896 shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+1.07%-2.54%+8.11%+9.40%+20.78%
Bruker Corporation stock logo
BRKR
Bruker
+5.34%+3.43%-8.23%-1.58%+77.61%
Revvity Inc. stock logo
RVTY
Revvity
+3.47%+3.70%+13.69%+27.94%+49.28%
Bio-Techne Corp stock logo
TECH
Bio-Techne
+0.17%-0.11%+0.22%+35.95%+35.34%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$148.40
-2.0%
$141.70
$108.35
$163.75
$41.92B1.242.24 million shs194,209 shs
Bruker Corporation stock logo
BRKR
Bruker
$57.92
-1.9%
$58.84
$28.95
$65.30
$8.81B1.262.36 million shs107,223 shs
Revvity Inc. stock logo
RVTY
Revvity
$128.14
-2.1%
$115.72
$81.22
$133.00
$14.29B1.091.40 million shs233,147 shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$72.36
+0.1%
$71.78
$43.19
$72.62
$11.35B1.283.36 million shs889,896 shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+1.07%-2.54%+8.11%+9.40%+20.78%
Bruker Corporation stock logo
BRKR
Bruker
+5.34%+3.43%-8.23%-1.58%+77.61%
Revvity Inc. stock logo
RVTY
Revvity
+3.47%+3.70%+13.69%+27.94%+49.28%
Bio-Techne Corp stock logo
TECH
Bio-Techne
+0.17%-0.11%+0.22%+35.95%+35.34%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.85
Moderate Buy$170.3312.64% Upside
Bruker Corporation stock logo
BRKR
Bruker
2.57
Moderate Buy$56.64-4.03% Downside
Revvity Inc. stock logo
RVTY
Revvity
2.19
Hold$110.58-15.57% Downside
Bio-Techne Corp stock logo
TECH
Bio-Techne
2.12
Hold$68.92-4.67% Downside

Current Analyst Ratings Breakdown

Latest RVTY, BRKR, TECH, and A Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/1/2026
Revvity Inc. stock logo
RVTY
Revvity
Initiated CoverageSector Perform$135.00
9/1/2026
Revvity Inc. stock logo
RVTY
Revvity
Initiated CoverageSector Perform$135.00
8/31/2026
Bruker Corporation stock logo
BRKR
Bruker
Reiterated RatingSell (D+)
8/28/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Reiterated RatingHold (C)
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetBuy$155.00 ➝ $175.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetBuy$185.00 ➝ $190.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetBuy$155.00 ➝ $180.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetBuy$170.00 ➝ $180.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetOverweight$150.00 ➝ $175.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetOverweight$180.00 ➝ $190.00
8/27/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetBuy$155.00 ➝ $180.00
(Data available from 9/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.95B6.15$6.69 per share22.61$26.07 per share5.80
Bruker Corporation stock logo
BRKR
Bruker
$3.44B2.62$3.56 per share16.60$15.75 per share3.75
Revvity Inc. stock logo
RVTY
Revvity
$2.91B5.02$9.12 per share14.36$64.78 per share2.02
Bio-Techne Corp stock logo
TECH
Bio-Techne
$1.22B9.33$2.35 per share30.75$13.44 per share5.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$5.0829.7722.342.2819.53%24.45%13.09%N/A
Bruker Corporation stock logo
BRKR
Bruker
-$8.60M-$0.70N/A24.291.71-2.35%12.47%4.91%11/2/2026 (Estimated)
Revvity Inc. stock logo
RVTY
Revvity
$241.20M$2.1062.3722.282.308.16%8.34%5.01%10/26/2026 (Estimated)
Bio-Techne Corp stock logo
TECH
Bio-Techne
$181.86M$1.1562.8735.978.6014.97%13.23%10.61%11/4/2026 (Estimated)

Latest RVTY, BRKR, TECH, and A Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/26/2026Q3 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.49$1.62+$0.13$1.28$1.84 billion$1.88 billion
8/12/2026Q4 2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.5190$0.52+$0.0010$0.35$314.63 million$321.19 million
8/4/2026Q2 2026
Bruker Corporation stock logo
BRKR
Bruker
$0.3849$0.49+$0.1051-$0.41$853.57 million$838.50 million
8/4/2026Q2 2026
Revvity Inc. stock logo
RVTY
Revvity
$1.21$1.41+$0.20$0.47$702.96 million$729.69 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.69%+6.58%20.08%9 Years
Bruker Corporation stock logo
BRKR
Bruker
$0.200.35%+4.56%N/A N/A
Revvity Inc. stock logo
RVTY
Revvity
$0.280.22%N/A13.33%N/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.320.44%N/A27.83%N/A

Latest RVTY, BRKR, TECH, and A Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/31/2026
Revvity Inc. stock logo
RVTY
Revvity
quarterly$0.070.25%10/23/202610/23/202611/13/2026
8/14/2026
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.35%9/21/20269/21/202610/7/2026
8/12/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.650.44%8/24/20268/24/20269/4/2026
8/12/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.080.44%8/17/20268/17/20268/28/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.50
2.05
1.56
Bruker Corporation stock logo
BRKR
Bruker
0.76
1.85
0.92
Revvity Inc. stock logo
RVTY
Revvity
0.36
1.80
1.50
Bio-Techne Corp stock logo
TECH
Bio-Techne
0.09
4.55
3.35

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bruker Corporation stock logo
BRKR
Bruker
79.52%
Revvity Inc. stock logo
RVTY
Revvity
86.65%
Bio-Techne Corp stock logo
TECH
Bio-Techne
98.95%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bruker Corporation stock logo
BRKR
Bruker
27.20%
Revvity Inc. stock logo
RVTY
Revvity
0.85%
Bio-Techne Corp stock logo
TECH
Bio-Techne
1.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100282.43 millionN/AOptionable
Bruker Corporation stock logo
BRKR
Bruker
11,085152.36 million110.92 millionOptionable
Revvity Inc. stock logo
RVTY
Revvity
11,000111.59 million110.64 millionOptionable
Bio-Techne Corp stock logo
TECH
Bio-Techne
3,000156.82 million154.78 millionOptionable

Recent News About These Companies

CMB.TECH NV (CMBT) Q2 2026 Earnings Call Transcript
Man Group plc Takes Position in Bio-Techne Corp $TECH

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$148.40 -3.00 (-1.98%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Bruker stock logo

Bruker NASDAQ:BRKR

$57.92 -1.10 (-1.86%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Revvity stock logo

Revvity NYSE:RVTY

$128.14 -2.80 (-2.14%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$72.36 +0.06 (+0.08%)
As of 10:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.